Papers/PMID:19336644
Effect of magnesium L-lactate on blood pressure in patients with an implantable cardioverter defibrillator.
The Annals of pharmacotherapy2009The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
magnesium(2+) — decreases systolic blood pressure (setting unspecified)
Evidence strength: very limited.Findingreplicated ×5“At 12 weeks, magnesium L-lactate significantly reduced systolic blood pressure compared with placebo (117.7 +/- 11.8 vs 126.3 +/- 16.7 mm Hg, respectively; p = 0.04).”
Quoted verbatim from Effect of magnesium L-lactate on blood pressure in patients with an implantable cardioverter defibrillator.. - Study
- RCT
- Duration
- 3 months
- Dose
- magnesium L-lactate, 6 tablets daily supplying 504 mg elemental magnesium
- Population
- Patients with implantable cardioverter defibrillators; 12-week timepoint (sitting systolic pressure)
Effect of magnesium L-lactate on blood pressure in patients with an implantable cardioverter defibrillator.2009PMID:1933664410.1345/aph.1L640Permalink